Table 6 Number and stage of lung cancer patients, with diagnosis by source of referral.

From: Evaluation of a national lung cancer symptom awareness campaign in Wales

 

2015 Number of cases (%)

2016 Number of cases (%)

n change

p-value

Number of new lung cancer cases

Non-small cell lung cancer

 Pre-campaign

324

326

2

 

 Campaign

348

372

24

0.34

 Post-campaign

342

318

−24

 

Small-cell lung cancer

  Pre-campaign

51

47

−4

 

  Campaign

53

40

−13

0.38

  Post-campaign

42

39

−3

 

Total

  Pre-campaign

375

373

−2

 

  Campaign

401

412

11

0.70

 Post-campaign

384

357

−27

 
 

2015 Number of cases (%)

2016 Number of cases (%)

% Change

p-value

Stage of new lung cancer cases number and proportion of cases with known stagea

Early (stage I and II)

  Pre-campaign

95 (25.5%)

85 (23.4%)

−2.1%

 

  Campaign

98 (24.8%)

114 (28.3%)

3.5%

0.27

  Post-campaign

114 (30.2%)

94 (27.0%)

−3.2%

 

Late (stage III and IV)

  Pre-campaign

277 (74.5%)

278 (76.6%)

2.1%

 

  Campaign

297 (75.1%)

289 (71.7%)

−3.5%

0.27

  Post-campaign

263 (69.8%)

254 (73.0%)

3.2%

 

Stage unknown

  Pre-campaign

3

10

  

  Campaignb

6

9

  

  Post-campaign

7

9

  

Number and proportion of new lung cancer cases diagnosed by source of referral

Following A&E attendance or emergency admission

  Pre-campaign

102 (27.2%)

111 (29.8%)

2.6%

 

  Campaign

89 (22.2%)

117 (28.5%)

6.3%

0.04

  Post-campaign

103 (26.8%)

108 (30.3%)

3.4%

 

Referral from GP

  Pre-campaign

176 (46.9%)

184 (49.3%)

2.4%

 

  Campaign

180 (44.9%)

171 (41.6%)

−3.3%

0.35

  Post-campaign

154 (40.1%)

146 (40.9%)

0.8%

 

Referral from a consultant (other than in an A&E department)

  Pre-campaign

73 (19.5%)

57 (15.3%)

−4.2%

 

  Campaign

112 (27.9%)

85 (20.7%)

−7.2%

0.02

  Post−campaign

103 (26.8%)

77 (21.6%)

−5.3%

 

Referral from a consultant (from inpatients)

   Pre-campaign

13 (3.5%)

9 (2.4%)

−1.1%

 

  Campaign

16 (4.0%)

24 (5.8%)

1.8%

0.22

  Post-campaign

11 (2.9%)

16 (4.5%)

1.6%

 

Other source

  Pre-campaign

11 (2.9%)

12 (3.2%)

0.3%

 

  Campaign

4 (1.0%)

14 (3.4%)

2.4%

0.02

  Post-campaign

13 (3.4%)

10 (2.8%)

−0.6%

 

Not recorded

  Pre-campaign

0 (0%)

0 (0%)

0%

 

  Campaign

0 (0%)

1 (0.2%)

0.2%

 

  Post-campaign

0 (0%)

0 (0%)

0%

 
  1. aSmall-cell and non-small cell lung cancer cases combined; %’s presented as proportions of the total known cases
  2. bStatistical testing not conducted due to very small numbers